Sr. Data Analyst / Manager Data Analyst for Integrated Insight & Execution at Gilead Sciences

Tokyo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Ability to work with BU head, Sales Planning, Marketing, IT, and ComOps departments (SFE, Marketing Ops, Market Insights) on strategic and operational elements for Gilead Sciences Japan
Experience or capability as a data scientist driving Data Strategy, BI, and Advanced Analytics
Expertise in Cross Channel/Omni-Channel Analytics under Digital Transformation
Hands-on, agile approach with professional skills/techniques and deep business understanding for execution
Eagerness to understand pharma commercial business, related data, and data privacy/compliance
Ability to direct or provide reliable and accurate analysis and reports using data science to influence decision-making on key strategies

Responsibilities

Direct or provide reliable and accurate analysis and reports with data science to influence decision-making on key strategies
Support BU Marketing and Sales to generate insights from data by providing business narratives from data-driven situation analysis and facilitating discussions
Analyze omni-channel data based on understanding of marketing strategy and campaigns for each brand team, identifying actionable customer insights to share and suggest to marketing teams
Construct analytical models that simplify controls or analysis while maintaining data integrity

Skills

Data Analysis

Analytics

SQL

Python

Tableau

Excel

Data Visualization

Business Intelligence

Statistical Analysis

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free